Finally, we show that intramuscularly injected AAVMYO delivers transgenes to muscle-residing mononuclear cells in the dyW/dyW mouse model of LAMA2-related muscular dystrophy, demonstrating that these cells can be targeted to express therapeutic transgenes in the context of muscular diseases. The gene discussed is LAMA2; the disease is muscular dystrophy.